Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
Date:2/10/2011

xilium faces may be found under the heading "Risk Factors" in Auxilium's Annual Report on Form 10-K for the year ended December 31, 2009 and in Auxilium's Quarterly Report on Form 10-Q for the period ended September 30, 2010 which are on file with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of the forward-looking statements contained in this release may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Auxilium undertakes no obligation to update publicly any forward-looking statement.

AUXILIUM PHARMACEUTICALS, INC.Condensed Consolidated Statement of Operations(In thousands, except share and per share amounts)(Unaudited)Three Months Ended December 31,Twelve Months Ended December 31,2010200920102009Net revenues

$
,830$
48,027$   211,429$   164,039Operating expenses*:Cost of goods sold

17,16510,41649,72537,077Research and development

13,95411,37548,00551,398Selling, general and administrative

47,00838,711164,675129,181Total operating expenses

78,12760,502262,405217,656Loss from operations

(16,297)(12,475)(50,976)(53,617)Interest income (expense), net

(99)(38)(255)160Loss before income taxes

(16,396)(12,513)(51,231)(53,457)Provision for income taxes

-(614)--Net loss

$
(16,396)$
(11,899)$
(51,231)$
(53,457)Basic and diluted net loss percommon share

$
(0.34)$
(0.25)$
(1.08)$
(1.22)Weighted average common sharesoutstanding

47,666,40647,001,77947,426,84943,650,775*includes the following amountsof stock-based compensation expense:Cost of goods sold

$
46$
-$
55$
-Research and development

1,2831,0272,6985,048Selling, general and administrative

4,6203,33615,10912,852AUXILIUM PHARMACEUTICALS, INC.Selected Consolidated Balance Sheet Data(In thousands)(Unaudited)December 31,December 31,20102009Cash and cash equivalents'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
5. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
6. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
7. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
10. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... D.C., September 30, 2014 Applying a well-known ... researchers at Harvard University has demonstrated the ability ... -- work that holds promise for making future, ... detailing the sides of next-gen rocket ships and ... light passes through oil in water, it becomes ...
(Date:9/30/2014)... 30, 2014 Shimadzu Scientific Instruments ... easy-to-use and highly precise tool for measuring displacement ... elongation. With 1000-mm maximum movement distance, the DSES-1000 ... a gauge length of 10 mm. In addition, ... above 50-mm stroke and within +/- 100 µm ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  RegeneRx ... today announced that it has received a Canadian ... by Actin-Sequestering Peptides.  This patent includes claims using ... numerous other actin-sequestering peptides for these purposes.  The ... About RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... Sept. 30, 2014  KemPharm, Inc., a clinical-stage ... development of proprietary new molecular entity (NME) prodrugs, ... Trademark Office (USPTO) issued U.S. Patent No. 8,816,083 ... Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid ... Use Thereof." The patent, which extends ...
Breaking Biology Technology:Taking thin films to the extreme 2Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... Vice President of Regulatory Affairs and Vice President of ... ... NGSX ), a biopharmaceutical company focused on developing novel,pain management ... of Regulatory Affairs and Russell Kawahata, Ph.D. as,the Vice President of ...
... WAYNE, N.J., Oct. 9 A homegrown New ... that safeguards,the pedigree of pharmaceuticals everywhere. Secure Symbology, ... been chosen as an,Honored Finalist as Emerging Business ... being recognized for its vision to wipe out ...
... University HealthSystem Consortium With Broad ... Portfolio of ... (NYSE: BAX ) announced today that Novation, the University ... extension on behalf of UHC valued at over $200 million ...
Cached Biology Technology:NeurogesX Expands Senior Management Team 2NeurogesX Expands Senior Management Team 3Secure Symbology: Making New Jersey Proud While Saving Lives 2Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products 2Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products 3
(Date:9/30/2014)... of tourists visit the Mediterranean each year, but ... underway on Earth. Almost 1,000 alien species, including ... other seas through human activities. In the open-access ... multinational team of researchers analyzed data from a ... to show how the introduction of alien species ...
(Date:9/30/2014)... watermelon, salmon, and strawberries all have in common? ... of chromosomes and are diploid, these organisms are all ... chromosomesseedless watermelon and salmon have 3 and 4 sets ... this might seem surprising, in fact most plant species ... over a century ago, but only recently, with the ...
(Date:9/30/2014)... Prenatal exposure to tetrachloroethylene (PCE) in drinking water ... abruption, according to a new study led by ... , The study, published in the journal ... 1,019 unexposed pregnancies among 1,766 women in Cape ... late 1960s to the early 1980s by the ...
Breaking Biology News(10 mins):Biodiversity in the Mediterranean is threatened by alien species 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4Contaminated water linked to pregnancy complications, BU study finds 2
... A team of scientists from The Scripps Research Institute, ... among other institutions, has created a genetically modified fruit ... common neurodegenerative disorder that strikes about one out of ... As described in an article published in an Early ...
... , This release is available in ... of cells. Underneath their smooth surface they harbor an ... bottleneck like invaginations, which expand into elongated cavities (cristae). ... the cristae (,crista junction,) allows separation of the intracristal ...
... A two-tiered scanning-protocol for inspecting all containers at international ... containers moving through the global transportation system are not ... at a services special interest group meeting of the ... , The authors challenge the federal scheme now in ...
Cached Biology News:Scripps Research scientists observe human neurodegenerative disorder in fruit flies 2Scripps Research scientists observe human neurodegenerative disorder in fruit flies 3How mitochondria get their membranes bent 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 3Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 4
...
...
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research...
... The GeneSwitch Cell Lines stably ... pSwitch. Each cell line is functionally ... transfection with the expression control vector ... expression after treatment with mifepristone (Figure ...
Biology Products: